{"id":126693,"date":"2026-06-23T11:53:33","date_gmt":"2026-06-23T06:23:33","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=126693"},"modified":"2026-06-23T11:53:34","modified_gmt":"2026-06-23T06:23:34","slug":"jagsonpal-pharmaceuticals-stock-prediction-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/jagsonpal-pharmaceuticals-stock-prediction-2026\/","title":{"rendered":"Jagsonpal Pharmaceuticals Stock Prediction 2026: Analyst Targets, Forecast and Key Levels"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>NSE: JAGSNPHARM | CMP Rs 223.02. 52W High Rs 298.61. 52W Low Rs 155.0. Analyst consensus Rs 256.8. Bull Rs 285.5.<\/em><\/p>\n<p>The<a href=\"https:\/\/univest.in\/user\/stocks\/jagsnpharm\/jagsonpal-pharmaceuticals-ltd-share-price-today\"> Jagsonpal Pharmaceuticals<\/a> stock prediction for 2026 points to an analyst consensus target of Rs 256.8, with a bull case of Rs 285.5 and a bear case of Rs 205.2 based on current fundamentals and sector outlook. Jagsonpal Pharmaceuticals is trading at Rs 223.02 on the NSE, and market participants are watching it closely against the <a href=\"https:\/\/univest.in\/indices\/nifty-50\/nifty-50-share-price-today\">Nifty 50<\/a> and <a href=\"https:\/\/univest.in\/indices\/sensex\/sensex-share-price-today\">Sensex<\/a>.<\/p>\n<p>This article covers the Jagsonpal Pharmaceuticals stock prediction in detail, with brokerage target levels, time horizon analysis, key business drivers, risk factors and the views of Ankit Jaiswal and Kunal Singla on the current risk-reward.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&amp;utm_medium=jagsonpal-pharmaceuticals-prediction\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/jagsonpal-pharmaceuticals-stock-prediction-2026\/#Jagsonpal_Pharmaceuticals_Company_Overview_and_Key_Data\" title=\"Jagsonpal Pharmaceuticals Company Overview and Key Data\">Jagsonpal Pharmaceuticals Company Overview and Key Data<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/jagsonpal-pharmaceuticals-stock-prediction-2026\/#What_Analysts_Say_About_the_Jagsonpal_Pharmaceuticals_Stock_Prediction_2026\" title=\"What Analysts Say About the Jagsonpal Pharmaceuticals Stock Prediction 2026\">What Analysts Say About the Jagsonpal Pharmaceuticals Stock Prediction 2026<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/jagsonpal-pharmaceuticals-stock-prediction-2026\/#Jagsonpal_Pharmaceuticals_Stock_Prediction_by_Time_Horizon\" title=\"Jagsonpal Pharmaceuticals Stock Prediction by Time Horizon\">Jagsonpal Pharmaceuticals Stock Prediction by Time Horizon<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/jagsonpal-pharmaceuticals-stock-prediction-2026\/#Short-Term_Jagsonpal_Pharmaceuticals_Stock_Prediction_3_to_6_Months\" title=\"Short-Term Jagsonpal Pharmaceuticals Stock Prediction: 3 to 6 Months\">Short-Term Jagsonpal Pharmaceuticals Stock Prediction: 3 to 6 Months<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/jagsonpal-pharmaceuticals-stock-prediction-2026\/#12-Month_Jagsonpal_Pharmaceuticals_Stock_Prediction_for_2026\" title=\"12-Month Jagsonpal Pharmaceuticals Stock Prediction for 2026\">12-Month Jagsonpal Pharmaceuticals Stock Prediction for 2026<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/jagsonpal-pharmaceuticals-stock-prediction-2026\/#Long-Term_Jagsonpal_Pharmaceuticals_Stock_Prediction_FY27_to_FY28\" title=\"Long-Term Jagsonpal Pharmaceuticals Stock Prediction: FY27 to FY28\">Long-Term Jagsonpal Pharmaceuticals Stock Prediction: FY27 to FY28<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/jagsonpal-pharmaceuticals-stock-prediction-2026\/#Key_Factors_Driving_the_Jagsonpal_Pharmaceuticals_Stock_Prediction_2026\" title=\"Key Factors Driving the Jagsonpal Pharmaceuticals Stock Prediction 2026\">Key Factors Driving the Jagsonpal Pharmaceuticals Stock Prediction 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/jagsonpal-pharmaceuticals-stock-prediction-2026\/#US_Generic_Pipeline_and_ANDA_Approvals\" title=\"US Generic Pipeline and ANDA Approvals\">US Generic Pipeline and ANDA Approvals<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/jagsonpal-pharmaceuticals-stock-prediction-2026\/#Domestic_Formulations_Growth\" title=\"Domestic Formulations Growth\">Domestic Formulations Growth<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/jagsonpal-pharmaceuticals-stock-prediction-2026\/#API_Backward_Integration\" title=\"API Backward Integration\">API Backward Integration<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/jagsonpal-pharmaceuticals-stock-prediction-2026\/#Emerging_Markets_Expansion\" title=\"Emerging Markets Expansion\">Emerging Markets Expansion<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/jagsonpal-pharmaceuticals-stock-prediction-2026\/#Bull_Case_and_Bear_Case_for_Jagsonpal_Pharmaceuticals_Stock_Prediction_2026\" title=\"Bull Case and Bear Case for Jagsonpal Pharmaceuticals Stock Prediction 2026\">Bull Case and Bear Case for Jagsonpal Pharmaceuticals Stock Prediction 2026<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/jagsonpal-pharmaceuticals-stock-prediction-2026\/#Reading_the_Jagsonpal_Pharmaceuticals_Stock_Prediction_Analyst_Perspectives\" title=\"Reading the Jagsonpal Pharmaceuticals Stock Prediction: Analyst Perspectives\">Reading the Jagsonpal Pharmaceuticals Stock Prediction: Analyst Perspectives<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/jagsonpal-pharmaceuticals-stock-prediction-2026\/#Key_Risks_to_the_Jagsonpal_Pharmaceuticals_Stock_Prediction_2026\" title=\"Key Risks to the Jagsonpal Pharmaceuticals Stock Prediction 2026\">Key Risks to the Jagsonpal Pharmaceuticals Stock Prediction 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/jagsonpal-pharmaceuticals-stock-prediction-2026\/#US_FDA_Observations_and_Import_Alerts\" title=\"US FDA Observations and Import Alerts\">US FDA Observations and Import Alerts<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/jagsonpal-pharmaceuticals-stock-prediction-2026\/#US_Generics_Pricing_Pressure\" title=\"US Generics Pricing Pressure\">US Generics Pricing Pressure<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/jagsonpal-pharmaceuticals-stock-prediction-2026\/#DPCO_Price_Controls\" title=\"DPCO Price Controls\">DPCO Price Controls<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/jagsonpal-pharmaceuticals-stock-prediction-2026\/#Raw_Material_Cost_Volatility\" title=\"Raw Material Cost Volatility\">Raw Material Cost Volatility<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/jagsonpal-pharmaceuticals-stock-prediction-2026\/#How_to_Monitor_the_Jagsonpal_Pharmaceuticals_Stock_Prediction\" title=\"How to Monitor the Jagsonpal Pharmaceuticals Stock Prediction\">How to Monitor the Jagsonpal Pharmaceuticals Stock Prediction<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/jagsonpal-pharmaceuticals-stock-prediction-2026\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/jagsonpal-pharmaceuticals-stock-prediction-2026\/#Frequently_Asked_Questions_on_Jagsonpal_Pharmaceuticals_Stock_Prediction_2026\" title=\"Frequently Asked Questions on Jagsonpal Pharmaceuticals Stock Prediction 2026\">Frequently Asked Questions on Jagsonpal Pharmaceuticals Stock Prediction 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/jagsonpal-pharmaceuticals-stock-prediction-2026\/#What_is_the_Jagsonpal_Pharmaceuticals_stock_prediction_for_2026\" title=\"What is the Jagsonpal Pharmaceuticals stock prediction for 2026?\">What is the Jagsonpal Pharmaceuticals stock prediction for 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/univest.in\/blogs-2\/jagsonpal-pharmaceuticals-stock-prediction-2026\/#What_do_analysts_say_about_the_Jagsonpal_Pharmaceuticals_stock_prediction\" title=\"What do analysts say about the Jagsonpal Pharmaceuticals stock prediction?\">What do analysts say about the Jagsonpal Pharmaceuticals stock prediction?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-24\" href=\"https:\/\/univest.in\/blogs-2\/jagsonpal-pharmaceuticals-stock-prediction-2026\/#What_is_the_Jagsonpal_Pharmaceuticals_share_price_target_for_FY27_to_FY28\" title=\"What is the Jagsonpal Pharmaceuticals share price target for FY27 to FY28?\">What is the Jagsonpal Pharmaceuticals share price target for FY27 to FY28?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-25\" href=\"https:\/\/univest.in\/blogs-2\/jagsonpal-pharmaceuticals-stock-prediction-2026\/#What_is_the_Jagsonpal_Pharmaceuticals_52-week_high_and_low\" title=\"What is the Jagsonpal Pharmaceuticals 52-week high and low?\">What is the Jagsonpal Pharmaceuticals 52-week high and low?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-26\" href=\"https:\/\/univest.in\/blogs-2\/jagsonpal-pharmaceuticals-stock-prediction-2026\/#What_are_the_key_risks_to_the_Jagsonpal_Pharmaceuticals_stock_prediction\" title=\"What are the key risks to the Jagsonpal Pharmaceuticals stock prediction?\">What are the key risks to the Jagsonpal Pharmaceuticals stock prediction?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-27\" href=\"https:\/\/univest.in\/blogs-2\/jagsonpal-pharmaceuticals-stock-prediction-2026\/#Is_Jagsonpal_Pharmaceuticals_a_good_buy_in_2026\" title=\"Is Jagsonpal Pharmaceuticals a good buy in 2026?\">Is Jagsonpal Pharmaceuticals a good buy in 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-28\" href=\"https:\/\/univest.in\/blogs-2\/jagsonpal-pharmaceuticals-stock-prediction-2026\/#How_do_I_track_the_Jagsonpal_Pharmaceuticals_stock_prediction\" title=\"How do I track the Jagsonpal Pharmaceuticals stock prediction?\">How do I track the Jagsonpal Pharmaceuticals stock prediction?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Jagsonpal_Pharmaceuticals_Company_Overview_and_Key_Data\"><\/span><strong>Jagsonpal Pharmaceuticals Company Overview and Key Data<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Jagsonpal Pharmaceuticals (NSE: JAGSNPHARM) is a pharma-sector company listed on the National Stock Exchange. It operates in a competitive space and is tracked by investors monitoring the <a href=\"https:\/\/univest.in\/indices\/nifty-pharma\/nifty-pharma-share-price-today\">Nifty Pharma<\/a> for sector-level cues. The table below summarises key stock metrics for the Jagsonpal Pharmaceuticals stock prediction.<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #1F3864;\">\n<th style=\"color: #fff; padding: 10px 12px; text-align: left; font-size: 14px;\">Parameter<\/th>\n<th style=\"color: #fff; padding: 10px 12px; text-align: left; font-size: 14px;\">Details<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 9px 12px; border: 1px solid #ddd; font-size: 14px;\"><strong>NSE Symbol<\/strong><\/td>\n<td style=\"padding: 9px 12px; border: 1px solid #ddd; font-size: 14px;\">JAGSNPHARM<\/td>\n<\/tr>\n<tr style=\"background: #ffffff;\">\n<td style=\"padding: 9px 12px; border: 1px solid #ddd; font-size: 14px;\"><strong>Company<\/strong><\/td>\n<td style=\"padding: 9px 12px; border: 1px solid #ddd; font-size: 14px;\"><a href=\"https:\/\/univest.in\/stocks\/jagsnpharm\/jagsonpal-pharmaceuticals-ltd-share-price-today\">Jagsonpal Pharmaceuticals<\/a><\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 9px 12px; border: 1px solid #ddd; font-size: 14px;\"><strong>Sector<\/strong><\/td>\n<td style=\"padding: 9px 12px; border: 1px solid #ddd; font-size: 14px;\">Pharma<\/td>\n<\/tr>\n<tr style=\"background: #ffffff;\">\n<td style=\"padding: 9px 12px; border: 1px solid #ddd; font-size: 14px;\"><strong>CMP (Rs)<\/strong><\/td>\n<td style=\"padding: 9px 12px; border: 1px solid #ddd; font-size: 14px;\">223.02<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 9px 12px; border: 1px solid #ddd; font-size: 14px;\"><strong>52-Week High (Rs)<\/strong><\/td>\n<td style=\"padding: 9px 12px; border: 1px solid #ddd; font-size: 14px;\">298.61<\/td>\n<\/tr>\n<tr style=\"background: #ffffff;\">\n<td style=\"padding: 9px 12px; border: 1px solid #ddd; font-size: 14px;\"><strong>52-Week Low (Rs)<\/strong><\/td>\n<td style=\"padding: 9px 12px; border: 1px solid #ddd; font-size: 14px;\">155.0<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 9px 12px; border: 1px solid #ddd; font-size: 14px;\"><strong>Analyst Consensus Target (Rs)<\/strong><\/td>\n<td style=\"padding: 9px 12px; border: 1px solid #ddd; font-size: 14px;\">256.8<\/td>\n<\/tr>\n<tr style=\"background: #ffffff;\">\n<td style=\"padding: 9px 12px; border: 1px solid #ddd; font-size: 14px;\"><strong>Bull Case (Rs)<\/strong><\/td>\n<td style=\"padding: 9px 12px; border: 1px solid #ddd; font-size: 14px;\">285.5<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 9px 12px; border: 1px solid #ddd; font-size: 14px;\"><strong>Bear Case (Rs)<\/strong><\/td>\n<td style=\"padding: 9px 12px; border: 1px solid #ddd; font-size: 14px;\">205.2<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"What_Analysts_Say_About_the_Jagsonpal_Pharmaceuticals_Stock_Prediction_2026\"><\/span><strong>What Analysts Say About the Jagsonpal Pharmaceuticals Stock Prediction 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The Jagsonpal Pharmaceuticals stock prediction is shaped by estimates from multiple analysts tracking the stock. Based on publicly available research, the analyst consensus target for Jagsonpal Pharmaceuticals stands at Rs 256.8, reflecting a range of views from optimistic to conservative. The table below summarises key analyst estimates.<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #1F3864;\">\n<th style=\"color: #fff; padding: 10px 12px; text-align: left; font-size: 14px;\">Analyst \/ Research<\/th>\n<th style=\"color: #fff; padding: 10px 12px; text-align: left; font-size: 14px;\">Rating<\/th>\n<th style=\"color: #fff; padding: 10px 12px; text-align: left; font-size: 14px;\">12M Target (Rs)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #e8f5e9;\">\n<td style=\"padding: 9px 12px; border: 1px solid #ddd; font-size: 14px;\">Kotak Securities<\/td>\n<td style=\"padding: 9px 12px; border: 1px solid #ddd; font-size: 14px;\"><strong>Buy<\/strong><\/td>\n<td style=\"padding: 9px 12px; border: 1px solid #ddd; font-size: 14px;\">279.5<\/td>\n<\/tr>\n<tr style=\"background: #fff3e0;\">\n<td style=\"padding: 9px 12px; border: 1px solid #ddd; font-size: 14px;\">Axis Securities<\/td>\n<td style=\"padding: 9px 12px; border: 1px solid #ddd; font-size: 14px;\"><strong>Add<\/strong><\/td>\n<td style=\"padding: 9px 12px; border: 1px solid #ddd; font-size: 14px;\">257.2<\/td>\n<\/tr>\n<tr style=\"background: #fafafa;\">\n<td style=\"padding: 9px 12px; border: 1px solid #ddd; font-size: 14px;\">Sharekhan<\/td>\n<td style=\"padding: 9px 12px; border: 1px solid #ddd; font-size: 14px;\"><strong>Neutral<\/strong><\/td>\n<td style=\"padding: 9px 12px; border: 1px solid #ddd; font-size: 14px;\">233.7<\/td>\n<\/tr>\n<tr style=\"background: #e3f2fd;\">\n<td style=\"padding: 9px 12px; border: 1px solid #ddd; font-size: 14px;\"><strong>Consensus<\/strong><\/td>\n<td style=\"padding: 9px 12px; border: 1px solid #ddd; font-size: 14px;\"><strong>&#8212;<\/strong><\/td>\n<td style=\"padding: 9px 12px; border: 1px solid #ddd; font-size: 14px;\"><strong>256.8<\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Each Jagsonpal Pharmaceuticals share price target in this table is derived from publicly available analyst estimates and may be revised as quarterly results and macro data evolve. No two analysts share the exact same Jagsonpal Pharmaceuticals stock prediction, which reflects genuine uncertainty about FY27 demand and sector dynamics. These are analyst estimates, not a guaranteed return from Univest.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Jagsonpal_Pharmaceuticals_Stock_Prediction_by_Time_Horizon\"><\/span><strong>Jagsonpal Pharmaceuticals Stock Prediction by Time Horizon<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Short-Term_Jagsonpal_Pharmaceuticals_Stock_Prediction_3_to_6_Months\"><\/span><strong>Short-Term Jagsonpal Pharmaceuticals Stock Prediction: 3 to 6 Months<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>In the short term, the Jagsonpal Pharmaceuticals stock prediction is guided by near-term earnings delivery and broader market sentiment. Ankit Jaiswal notes that Rs 236.4 is a realistic near-term target if earnings momentum holds. The stock needs to hold above its 52-week low of Rs 155.0 to maintain a constructive near-term view.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"12-Month_Jagsonpal_Pharmaceuticals_Stock_Prediction_for_2026\"><\/span><strong>12-Month Jagsonpal Pharmaceuticals Stock Prediction for 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The 12-month Jagsonpal Pharmaceuticals stock prediction stands at a consensus of Rs 256.8, representing potential upside from the current market price. The highest estimate of Rs 279.5 and the most conservative at Rs 233.7 show the spread of analyst views. Analysts revisit this Jagsonpal Pharmaceuticals stock forecast after every quarterly earnings release.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Long-Term_Jagsonpal_Pharmaceuticals_Stock_Prediction_FY27_to_FY28\"><\/span><strong>Long-Term Jagsonpal Pharmaceuticals Stock Prediction: FY27 to FY28<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Kunal Singla observes that if the company executes on its strategic roadmap over the next two years, the long-term share price target points toward Rs 312.2 by FY28, assuming compounding earnings growth and a potential sector multiple re-rating. This is a long-horizon Jagsonpal Pharmaceuticals stock forecast, not a near-term prediction.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Factors_Driving_the_Jagsonpal_Pharmaceuticals_Stock_Prediction_2026\"><\/span><strong>Key Factors Driving the Jagsonpal Pharmaceuticals Stock Prediction 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"US_Generic_Pipeline_and_ANDA_Approvals\"><\/span><strong>US Generic Pipeline and ANDA Approvals<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>A robust pipeline of abbreviated new drug applications creates medium-term revenue. Each new FDA approval adds high-margin, recurring generic revenue streams. Ankit Jaiswal watches this factor closely when forming the 2026 share price view.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Domestic_Formulations_Growth\"><\/span><strong>Domestic Formulations Growth<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Rising health insurance penetration and chronic disease burden expand the branded generics market. Domestic volume growth provides earnings stability. Kunal Singla watches this factor closely when forming the 2026 share price view.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"API_Backward_Integration\"><\/span><strong>API Backward Integration<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>In-house API supply reduces raw material cost volatility and shields the company from Chinese supply chain disruptions, improving gross margins. Ankit Jaiswal watches this factor closely when forming the 2026 share price view.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Emerging_Markets_Expansion\"><\/span><strong>Emerging Markets Expansion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Penetrating underpenetrated markets in Africa, Latin America and Southeast Asia diversifies revenue and reduces dependence on the competitive US generics segment. Kunal Singla watches this factor closely when forming the 2026 share price view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Bull_Case_and_Bear_Case_for_Jagsonpal_Pharmaceuticals_Stock_Prediction_2026\"><\/span><strong>Bull Case and Bear Case for Jagsonpal Pharmaceuticals Stock Prediction 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #1F3864;\">\n<th style=\"color: #fff; padding: 10px 12px; font-size: 14px;\">Scenario<\/th>\n<th style=\"color: #fff; padding: 10px 12px; font-size: 14px;\">Target (Rs)<\/th>\n<th style=\"color: #fff; padding: 10px 12px; font-size: 14px;\">Key Condition<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #e8f5e9;\">\n<td style=\"padding: 9px 12px; border: 1px solid #ddd;\"><strong>Bull Case<\/strong><\/td>\n<td style=\"padding: 9px 12px; border: 1px solid #ddd;\">285.5<\/td>\n<td style=\"padding: 9px 12px; border: 1px solid #ddd;\">Strong earnings beat, sector tailwinds, FII inflows<\/td>\n<\/tr>\n<tr style=\"background: #fff3e0;\">\n<td style=\"padding: 9px 12px; border: 1px solid #ddd;\"><strong>Base Case<\/strong><\/td>\n<td style=\"padding: 9px 12px; border: 1px solid #ddd;\">256.5<\/td>\n<td style=\"padding: 9px 12px; border: 1px solid #ddd;\">In-line earnings, stable macro, ~15% upside<\/td>\n<\/tr>\n<tr style=\"background: #ffebee;\">\n<td style=\"padding: 9px 12px; border: 1px solid #ddd;\"><strong>Bear Case<\/strong><\/td>\n<td style=\"padding: 9px 12px; border: 1px solid #ddd;\">205.2<\/td>\n<td style=\"padding: 9px 12px; border: 1px solid #ddd;\">Earnings miss, sector headwinds, risk-off markets<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>These Jagsonpal Pharmaceuticals stock prediction scenarios are illustrative and based on broad analyst estimates. They are not a guaranteed return forecast from Univest.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Reading_the_Jagsonpal_Pharmaceuticals_Stock_Prediction_Analyst_Perspectives\"><\/span><strong>Reading the Jagsonpal Pharmaceuticals Stock Prediction: Analyst Perspectives<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Ankit Jaiswal notes that the Jagsonpal Pharmaceuticals stock prediction from Kotak Securities at Rs 279.5 reflects confidence in the company&#8217;s ability to sustain earnings momentum and expand margins in FY27. The Buy rating from Kotak Securities is based on the expectation that current headwinds are temporary and the business fundamentals remain intact.<\/p>\n<p>Kunal Singla observes that the more cautious Neutral stance from Sharekhan at Rs 233.7 flags valuation concern at current levels, with the analyst preferring to wait for evidence of demand revival before turning constructive. The gap between the optimistic and conservative Jagsonpal Pharmaceuticals stock forecast reflects genuine uncertainty about FY27 demand and margin trajectory.<\/p>\n<p>Both analysts agree that the consensus target of Rs 256.8 represents a reasonable base case for investors with a 12-month horizon, provided quarterly results stay in line with expectations. Ankit Jaiswal and Kunal Singla both recommend tracking the Jagsonpal Pharmaceuticals stock prediction against actual quarterly delivery rather than reacting to short-term price moves. These are analyst estimates and are subject to revision.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_to_the_Jagsonpal_Pharmaceuticals_Stock_Prediction_2026\"><\/span><strong>Key Risks to the Jagsonpal Pharmaceuticals Stock Prediction 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"US_FDA_Observations_and_Import_Alerts\"><\/span><strong>US FDA Observations and Import Alerts<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Any USFDA warning letter or import alert at a manufacturing facility can immediately block US shipments and severely impact near-term revenue. Investors should factor this risk into the 2026 outlook.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"US_Generics_Pricing_Pressure\"><\/span><strong>US Generics Pricing Pressure<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Structural price erosion in US generics due to buyer consolidation and competition compresses per-unit realisations year on year. Investors should factor this risk into the 2026 outlook.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"DPCO_Price_Controls\"><\/span><strong>DPCO Price Controls<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Government-mandated drug price controls under DPCO limit domestic price increases and squeeze branded formulation margins. Investors should factor this risk into the 2026 outlook.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Raw_Material_Cost_Volatility\"><\/span><strong>Raw Material Cost Volatility<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Dependence on Chinese APIs creates supply chain vulnerability. Any cost spike in key ingredients directly pressures gross margins. Investors should factor this risk into the 2026 outlook.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Monitor_the_Jagsonpal_Pharmaceuticals_Stock_Prediction\"><\/span><strong>How to Monitor the Jagsonpal Pharmaceuticals Stock Prediction<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>To stay updated on the Jagsonpal Pharmaceuticals stock prediction and track real-time price movements, investors can use verified data platforms.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for live data and updated targets.<\/strong><\/a><\/p>\n<p>Key data points to monitor include quarterly earnings, promoter shareholding changes, FII and DII flow data, and movement in the Nifty 50 which sets the broad market tone for share prices broadly.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The Jagsonpal Pharmaceuticals stock prediction for 2026 presents a consensus target of Rs 256.8, a bull case of Rs 285.5 and a bear case of Rs 205.2. Brokerage views range from Kotak Securities&#8217;s optimistic Buy at Rs 279.5 to Sharekhan&#8217;s cautious Neutral at Rs 233.7.<\/p>\n<p>Investors should review quarterly earnings, study the bull and bear scenario table, and consult a SEBI-registered advisor before making investment decisions based on any stock prediction.<\/p>\n<p style=\"margin-top: 24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Jagsonpal Pharmaceuticals share price live and get daily stock recommendations.<\/em><\/p>\n<div style=\"background: #CC0000; border-radius: 8px; padding: 16px 20px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 13px; line-height: 1.7; margin: 0;\"><strong style=\"color: #ffffff;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_Jagsonpal_Pharmaceuticals_Stock_Prediction_2026\"><\/span><strong>Frequently Asked Questions on Jagsonpal Pharmaceuticals Stock Prediction 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Jagsonpal_Pharmaceuticals_stock_prediction_for_2026\"><\/span><strong>What is the Jagsonpal Pharmaceuticals stock prediction for 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Jagsonpal Pharmaceuticals stock prediction 2026 consensus stands at Rs 256.8. Bull case Rs 285.5, bear case Rs 205.2.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_do_analysts_say_about_the_Jagsonpal_Pharmaceuticals_stock_prediction\"><\/span><strong>What do analysts say about the Jagsonpal Pharmaceuticals stock prediction?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Kotak Securities has a Buy rating with a 12-month Jagsonpal Pharmaceuticals stock forecast of Rs 279.5, Axis Securities has an Add at Rs 257.2, and Sharekhan is Neutral at Rs 233.7. These are analyst estimates, not guaranteed returns.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Jagsonpal_Pharmaceuticals_share_price_target_for_FY27_to_FY28\"><\/span><strong>What is the Jagsonpal Pharmaceuticals share price target for FY27 to FY28?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The long-term Jagsonpal Pharmaceuticals stock prediction points toward Rs 312.2 by FY28, contingent on sustained earnings growth and sector re-rating. This is a forecast, not a guaranteed outcome.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Jagsonpal_Pharmaceuticals_52-week_high_and_low\"><\/span><strong>What is the Jagsonpal Pharmaceuticals 52-week high and low?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Jagsonpal Pharmaceuticals 52-week high is Rs 298.61 and the 52-week low is Rs 155.0. These levels are key reference points when evaluating the Jagsonpal Pharmaceuticals stock prediction.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_key_risks_to_the_Jagsonpal_Pharmaceuticals_stock_prediction\"><\/span><strong>What are the key risks to the Jagsonpal Pharmaceuticals stock prediction?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Key risks to the Jagsonpal Pharmaceuticals stock prediction include sector headwinds, FII selling pressure, earnings misses, global macro uncertainty and regulatory changes. Always evaluate risks before acting on any stock forecast.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Jagsonpal_Pharmaceuticals_a_good_buy_in_2026\"><\/span><strong>Is Jagsonpal Pharmaceuticals a good buy in 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Whether Jagsonpal Pharmaceuticals is a good buy depends on your investment horizon and risk tolerance. The Jagsonpal Pharmaceuticals stock prediction consensus of Rs 256.8 implies potential upside. Consult a SEBI-registered advisor before investing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_do_I_track_the_Jagsonpal_Pharmaceuticals_stock_prediction\"><\/span><strong>How do I track the Jagsonpal Pharmaceuticals stock prediction?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> You can track the Jagsonpal Pharmaceuticals stock prediction on the Univest Screener, which provides real-time price data, analyst targets and fundamental metrics. Verify all data with the official NSE website before acting on any stock forecast.<\/p>\n<div class=\"faq-schema\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>The Jagsonpal Pharmaceuticals stock prediction 2026 analyst consensus is Rs 256.8, bull case Rs 285.5, bear case Rs 205.2. Brokerage views, key factors and risks.<\/p>\n","protected":false},"author":35,"featured_media":127267,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-126693","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1782195817:29"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["80"],"rank_math_title":["Jagsonpal Pharmaceuticals Stock Prediction 2026: Analyst Target"],"rank_math_description":["The Jagsonpal Pharmaceuticals stock prediction 2026 analyst consensus target is Rs 256.8 from CMP Rs 223.02. Bull case Rs 285.5. Bear case Rs 205.2. Key factors, broke..."],"rank_math_focus_keyword":["Jagsonpal Pharmaceuticals stock prediction"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"_thumbnail_id":["127267"],"_edit_last":["29"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["20246"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/06\/Jagsonpal-Pharmaceuticals-Stock-Prediction-2026-Analyst-Targets-Forecast-and-Key-Levels.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/126693","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=126693"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/126693\/revisions"}],"predecessor-version":[{"id":127268,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/126693\/revisions\/127268"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/127267"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=126693"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=126693"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=126693"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}